Literature DB >> 23869074

Scouting out the neighborhood in AIDS-related lymphoma.

Kieron Dunleavy1, Catherine M Bollard.   

Abstract

In this issue of Blood, Liapis et al investigate the characteristics of the tumor microenvironment as well as the role of viral components in AIDS-related diffuse large B-cell lymphoma (AR-DLBCL) and compare these findings with sporadic cases of DLBCL.

Entities:  

Mesh：

Year:  2013        PMID： 23869074      PMCID： PMC3716197          DOI： 10.1182/blood-2013-06-502591

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


  10 in total

1.  The microenvironment of AIDS-related diffuse large B-cell lymphoma provides insight into the pathophysiology and indicates possible therapeutic strategies.

Authors:  Konstantinos Liapis; Andrew Clear; Andrew Owen; Rita Coutinho; Paul Greaves; Abigail M Lee; Silvia Montoto; Maria Calaminici; John G Gribben
Journal:  Blood       Date:  2013-05-07       Impact factor: 22.113

2.  Good manufacturing practice-grade cytotoxic T lymphocytes specific for latent membrane proteins (LMP)-1 and LMP2 for patients with Epstein-Barr virus-associated lymphoma.

Authors:  Catherine M Bollard; Stephen Gottschalk; M Helen Huls; Ann M Leen; Adrian P Gee; Cliona M Rooney
Journal:  Cytotherapy       Date:  2011-03-01       Impact factor: 5.414

Review 3.  Inhibition of tumor angiogenesis by antibodies, synthetic small molecules and natural products.

Authors:  O Wahl; M Oswald; L Tretzel; E Herres; J Arend; T Efferth
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

4.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.

Authors:  A A Alizadeh; M B Eisen; R E Davis; C Ma; I S Lossos; A Rosenwald; J C Boldrick; H Sabet; T Tran; X Yu; J I Powell; L Yang; G E Marti; T Moore; J Hudson; L Lu; D B Lewis; R Tibshirani; G Sherlock; W C Chan; T C Greiner; D D Weisenburger; J O Armitage; R Warnke; R Levy; W Wilson; M R Grever; J C Byrd; D Botstein; P O Brown; L M Staudt
Journal:  Nature       Date:  2000-02-03       Impact factor: 49.962

5.  Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells.

Authors:  S Murono; H Inoue; T Tanabe; I Joab; T Yoshizaki; M Furukawa; J S Pagano
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

6.  HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2.

Authors:  Francesca Caccuri; Cinzia Giagulli; Antonella Bugatti; Anna Benetti; Giulio Alessandri; Domenico Ribatti; Stefania Marsico; Paola Apostoli; Mark A Slevin; Marco Rusnati; Carlos A Guzman; Simona Fiorentini; Arnaldo Caruso
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-17       Impact factor: 11.205

Review 7.  Angiogenesis and antiangiogenic therapy in non-Hodgkin's lymphoma.

Authors:  J Ruan; K Hajjar; S Rafii; J P Leonard
Journal:  Ann Oncol       Date:  2008-12-16       Impact factor: 32.976

8.  Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma.

Authors:  Kieron Dunleavy; Stefania Pittaluga; Myron S Czuczman; Sandeep S Dave; George Wright; Nicole Grant; Margaret Shovlin; Elaine S Jaffe; John E Janik; Louis M Staudt; Wyndham H Wilson
Journal:  Blood       Date:  2009-04-20       Impact factor: 22.113

9.  Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer.

Authors:  Catherine M Bollard; Stephen Gottschalk; Ann M Leen; Heidi Weiss; Karin C Straathof; George Carrum; Mariam Khalil; Meng-fen Wu; M Helen Huls; Chung-Che Chang; M Victoria Gresik; Adrian P Gee; Malcolm K Brenner; Cliona M Rooney; Helen E Heslop
Journal:  Blood       Date:  2007-07-03       Impact factor: 22.113

10.  Stromal gene signatures in large-B-cell lymphomas.

Authors:  G Lenz; G Wright; S S Dave; W Xiao; J Powell; H Zhao; W Xu; B Tan; N Goldschmidt; J Iqbal; J Vose; M Bast; K Fu; D D Weisenburger; T C Greiner; J O Armitage; A Kyle; L May; R D Gascoyne; J M Connors; G Troen; H Holte; S Kvaloy; D Dierickx; G Verhoef; J Delabie; E B Smeland; P Jares; A Martinez; A Lopez-Guillermo; E Montserrat; E Campo; R M Braziel; T P Miller; L M Rimsza; J R Cook; B Pohlman; J Sweetenham; R R Tubbs; R I Fisher; E Hartmann; A Rosenwald; G Ott; H-K Muller-Hermelink; D Wrench; T A Lister; E S Jaffe; W H Wilson; W C Chan; L M Staudt
Journal:  N Engl J Med       Date:  2008-11-27       Impact factor: 91.245
  10 in total
  1 in total

Review 1.  Allogeneic Stem Cell Transplantation in Myelofibrosis.

Authors:  Tania Jain; Ruben A Mesa; Jeanne M Palmer
Journal:  Biol Blood Marrow Transplant       Date:  2017-05-10       Impact factor: 5.742
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.